Discover open access scientific publications

Search, annotate, share and cite publications

Publications by K. Loh

High Rate of Morbid Central Line Associated Complications During Treatment With Dose-Adjusted R-Epoch Therapy for Non-Hodgkin Lymphoma

Hematological Oncology

English

Related publications

Dose-Adjusted Epoch for Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: A Stone Two Birds

Hematological Oncology

English

Bendamustine-Based Therapy as First-Line Treatment for Non-Hodgkin Lymphoma

English

Frequency, Risk Factors, and Outcomes of Central Nervous System Relapse in Lymphoma Patients Treated With Dose-Adjusted EPOCH Plus Rituximab

American Journal of Hematology

Hematology

2017

English

Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2014

English

Recent Advances in the First-Line Treatment of Follicular Non-Hodgkin Lymphoma

English

Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma—Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology Group

International Journal of Radiation Oncology Biology Physics

English

Treatment of Early Stages Hodgkin Lymphoma During Pregnancy

Mediterranean Journal of Hematology and Infectious Diseases

Infectious Diseases

Hematology

2018

English

A Phase I Trial of 19-28z Car-T Cells Post-High Dose Therapy and Autologous Transplantation (Hdt-Asct) for Relapsed and Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)

Hematological Oncology

English

Palliative Therapy for Recalcitrant Cutaneous T-Cell Lymphoma of the Hands and Feet With Low-Dose, High Dose-Rate Brachytherapy

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by K. Loh

High Rate of Morbid Central Line Associated Complications During Treatment With Dose-Adjusted R-Epoch Therapy for Non-Hodgkin Lymphoma

Related publications

Dose-Adjusted Epoch for Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: A Stone Two Birds

Bendamustine-Based Therapy as First-Line Treatment for Non-Hodgkin Lymphoma

Frequency, Risk Factors, and Outcomes of Central Nervous System Relapse in Lymphoma Patients Treated With Dose-Adjusted EPOCH Plus Rituximab

Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma

Recent Advances in the First-Line Treatment of Follicular Non-Hodgkin Lymphoma

Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma—Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology Group

Treatment of Early Stages Hodgkin Lymphoma During Pregnancy

A Phase I Trial of 19-28z Car-T Cells Post-High Dose Therapy and Autologous Transplantation (Hdt-Asct) for Relapsed and Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)

Palliative Therapy for Recalcitrant Cutaneous T-Cell Lymphoma of the Hands and Feet With Low-Dose, High Dose-Rate Brachytherapy